mocytosis, strongyloidosis, toxoplasmosis, zygomycosis, atypical mycobactcriosis. Esophagitis has been caused by cand idiasis, CMV ilnd herpes simplex virus. The J C Virus, a new human pilpovavirus has caused progressive rnultifocal leukoencephalopathy, cryptosporidiosis has caused ch ronic ent erocolitis and herpes simplex virus has also caused extensive mucocutaneous disease. Scveral recent papers have discussed in detail the role of these infecting agents. Perhaps the most important of all the infections is the Pneumocystis carinii pneumonia.
A rare type of malignancy of len seen in the victims of A IDS is Kaposi's Sarcoma. Several reports have detailed current outbreaks of Kaposi's Sarcoma in cases of AIDS. Until recently this was a rare tumor. Severe immunologic deficiencies have been detected in cases of Kaposi 's Sarcoma in homosexual men and Haitians. The immunologic parameters which have been studied include seru m immunoglObu lin levels, enumeration of B cell. T cells, T-cell subsets and quantitation of lymphocyte responsiveness to phytohemagglutinin (PHA) and pokeweed mitogen (PWM). Sites of disease include sl:in, lymph nodes, gastrointestinal tract, spleen and lung.
CMV antibodies have been found in 80 to 95 per cent of AIDS patients compared with 50 per cent in the general population. CMV has been cultured from DOI: http://dx.doi.org/10.5915/18-1-11735 the urine of homosexual men but not from the urine of heterosexual men. There is also evidence suggesting that CMV infections can be transmilled sexually. The Epstein-Barr Virus, EBV, has also been implicated. Amibodies for EBV have been found in very high concentrations in a group of AIDS patients.
The current concept of an etiologic agem is the retrovirus of human T-cell lymphoma virus, HTLV-III , which is an RNA virus with an inherent reverse transcriptase. HTLV-UI has been isolated from 18 of 2 1 patients with lymphadenopath y syndrome and 26 of 72 aduhs and juveniles with AIDS. It has not been isolated from 11 5 healthy heterosexuals. Antibody to this vi rus has been isolated from serum samples of 88 0 /0 of AIDS patient s and 79070 of patients with lymphadenopathy syndrome. Only I of 64 healthy patients had this antibody. The antibody appears to be di rected against a viral envelope protein. French investigators isolatcd a virus in the same family of viruses which may be the idelltical organism and has been referred to as a lymphadenopathy virus (LA V). They have defined a code protein of th is agent which can also be used for serologic evaluation. A third retrovirus isolate has been found in hemophiliacs. referred to as immunodeficiency associated virus (IDAVJ, it appears 10 be quite similar if not identical with the othcr two.
T rans mission of AIDS
Transm ission of the disease is probably through sexual contacts (anal, vagi nal or oral). blood transfusions. lise of contaminated needles (by drug users), intimate family contacts (skin infections), saliva, semen or urine. and possibly transmitted by the mother to the fetus in her womb. This pattern of transmission parallels that of hepatitis B virus infection .
Enorm ity o f the Probl em
The fir st report s on iSOlated cases of AIDS were publishcd by the CDC in the summer of 1979. As of November 26, 1984 physicians and health departments in the United States had reported 6,993 patients meeting the s urveillance definition for acquired immunodeficiency syn drome. More than 86% of the adult patients with AIDS and 821lJo of the pediatric patients have been reported since January 1983 . Three thous:.md three hundred and fony-two (48'10) of all reported patients arc known to have died (48'10 of the adults and 69'1. of the children), including 73% of patients diagnosed before January
1983.
Epidemiologists predict thaI the chance of su rvival beyond 5 years will be less than 35 per cenl. The gravity of these predictions is evident in the fact that before the days of vacci nation evcn small pox killed only 25 per ccnt of the victims.
Incubation Period
The incubation period for AIDS is thought to be 6 to 8 months and possibly as long as 2 years. That means, a person who has recelllly been infected with a virus causing AIDS may not deVelop symptoms for many months and thus remain in the dark about the existence of this fatal disease for up to 2 years.
T he Most Likely Victims
The analysis of cascs in the United States allows identification of scvera l groups thai are at increased risk for developing AIDS. The high-risk groups are: The homosexuals form by far, the largest group, accounting for 71 per cenl of all of the 6,993 reported cases. The drug abusers rank second with 17 per cenl of all cases of A I DS. It is a mystery as to why Haitians have emerged as a high-risk group. Five per cent of AIDS cases arc Haitian men and women, especially those who came 10 the U.S. within the past few years. AIDS is the second leading cause of death in hemophiliacs, ranking second to uncontrollable bleeding. Eleven cases of unexplained infections and immune deficiency have been diagnosed in patients with hemophilia in recent months. Patients receiving blood or blood product transfu sion have also been know to contract AIDS. There have been 13 such cases. Insta nces of AIDS in previously healthy women also have been recorded.
In addition to the patient s in the high risk group, Chamberland el al reported 201 cases of the acquired immunodeficiency synd rome in persons who could not be classified into a group identified to be at increased risk for this syndrome. Thirty-five had received transfusion of single donor blood components in the 5 years preceding diagnosis of Ihe syndrome and 30 were sexual partners of persons belonging to a high risk group. However, information was incom plete for mOst remaining palients, but because many of these patients are demographically similar to populations recognized to be at increased risk for the syndrome, previously identified risk factors may have been present but not reported for so me of them. Addilionally, a few persons who meet the case definition for the syndrome probably had other reasons for the opportunistic disease and did not have the acquired immunodeficiency syndrome. The slow emergence of the acquired immunodeficiency syndrome in new populations is consistent with transmission mediated through sexual contact or parental exposure to blood.
Symptoms lind signs of AIDS
The most common symptoms are fatigue (in 10 per cent), fever (in 40 per cenl) and night sweats (in 44 per cent). These symptoms persist for weeks or months. Some patients (28 per cenl) lose weight. Diarrhea is also a frequent complaint.
In cases of Pneumocyst is Carinii pneumonia fever is usually associated with shortness of breath. If the vict im has Kaposi's Sarcoma, he may have dark blue or purple-brown plaques or nodules in the skin . These are most commonly seen on lower extremities but may occur on any part of the body. Some patients experience headaches, loss of appetite and difficulty in swallowing and rarely they suffer from seizures and other neurological abnormalities.
A common feature of the disease is the en largement of lymph glands in the neck or groins. In about 26 per cent of the patients. there is also enlargement of liver and the spleen. Fungal infections and thrush are sometimes seen.
In children with immune deficiency the clinical picture consists of anemia (hypochromic mycrocytic), infections, failure to thrive, hepatosplenomegaly, recurrent febrile episodes, thrush and eczema-like rash.
Preyention and Control of A1DS
Seyeral organizations such as the National Gay Task Force, the National Hemophilia Foundation, the American Red Cross, the American Association of Blood Banks, and the American Association of Physicians for Human Rights have issued statement s on prevention and control of AIDS . All organizations. physicians. public and the press should share responsibility in disseminating available information on AIDS. The following recommendations should be followed by persons or organizations concerned. These will greatly help in controlling and preventing AIDS:
1. A person experiencing sy mptoms of AIDS should seek medical advice as soon as possible so that the physician can take a full history, perform a complete examination, carry out laboratory tests, and render appropriate advice. 2. Individuals in high-risk groups should realize that multiple sexual partners tend to increase the probability of developing AIDS. 3. Sexual contacts with persons known or suspected to have AIDS should be avoided. 
Treatment
There is a natural concern in the minds of those who are arnicted and even the ones who are not as to the dfcctiveness of treatment. It must be stressed at the outset that the disease has been resistant to treatment and response has been poor to various aggressive mcdications.
Most treatments aim at reversing the abnormality of immune deficiency. fighting cancer or fighting the virus.
Dr . Allan L. Goldstein of the George Washington University School of Medicine has shown that thymosin, a group of hormones secreted by thymus gland activates the immune system. Therefore, it is possible that thymosin can be use ful in the treatment of AIDS ir it is caused by malfunction'of the thymus gland.
Dr A drug called pentamidine, available through CDC, has been tried for Pneumocystis Carinii pneumonia with good results.
In general, the results of treatments are disappointing. There is no promise of cure o n the horizon . The prospects are well summarized by Dr. Henry Masur of the National Institute of Health who has said, "since patients with AIDS are susceptible to such a wide range of devastating infections and neoplasms (growths), real progress in this syndrome will probably be made by elucidating the mode of transmission of AIDS and the mechanisms of immunosuppression . II 
What Can a Physitian Do For His Patient?
Every physician should fami liarize himself with all aspects of AIDS. He should be able to render advice to the patient on symptoms of the disease, prevention of the syndrome and most importantly, conduct an examination to identify some of the signs such as enlarged glands, enlarged liver and spleen and skin changes. He should carry out investigations that may throw additional light on the possibility of the existence of this disease. For instance, he could order Anti-HBc test to detect possible AIDS infectivity in blood. This blood test is positive in 90 per cent of the victims of AIDS and in only S per cent of the general population. Other investigations may include chest x-ray, biopsy of skin lesions, virologic and fungal studies and immunologic tests . A summary of abnormal laboratory tests is presented in Table I . The physician should refer the patient to an appropriate place for further investigations if his office is not equipped to carry out the investigations. A great deal of compassion will be needed in dealing with the patients of AIDS The epidemic proportions of the disease, lack of knowledge of its cause, far from satisfactory treatments, poor prognosis and high fatality rates have created a disastrous impact on the society: I. The healthy population is concerned ahout the spread of the disease.
2. The contacts of the high-risk popu lation are anxious about their involvement. 3. The high-risk groups are developing a psychiatric syndrome of anxiety, depression , loss of selfrespect and fear of contracting the disease. 4 . Those who are known to suffer from the disease are fearful of death . They are carrying the social st igma of the disease. They are becoming " untouchables." They are raising cries of discrimination social discrimination, job discrimination, medical discrimination. The fright is so overwhelming that the AIDS victims are shunned by their comm unities, their fellow workers, and sometimes by their friend s and families, In New York, even funeral directors are wary of handling AIDS victims. The homosexual commu nity and the Haitians are outraged at such reactions.
Conclusions
HTLV-III/ LA V is currently the best viral candidate for the etiologic agent of AIDS. and proof of this causal role will probably come from either disease eradication by a vaccine or production of the disease by the agent in an animal model. Also we should soon be hearing about one or more sensiti ve and specific diagnostic lests for detecting the presence of the infection through the measuremem of specific antibody to the virus and serum or the identification of a product associated with virus replication. Such a test will allow us to determine when the infection-as opposed to the disease occurs and in particular to prevent transmission by contaminated blood or blood products. Furthermore, specific public health and personal measures needed to diminish the spread of AIDS from direct human contact will become obvious with this information. Even those serious efforts to treat chronic viral infection are only JUSt beginning, there are several obvious lessons we can learn from what has already been done . For example, the first need is for accurate data on natural history. If this virus is like most persistem viruses, there is a stage in the normal host that is associated with either minor or asymptomatic disease, and this probably constitutes the bulk o f infections, It is even possible that an infection by other agents acts as a cofactor or that multiple human re(roviral infections are required fo r the development of the severest form of the infection, full blown AIDS . For example, in recipients of o rgan allografts, in whom most of the same infectious and neoplastic complications occur, although less frequently, cytomegalovirus infections have a cofactor role with the clinically required immunosuppressant drugs in causing enhanced susceptibility. Of course, the ultimate test of our understanding will be whether we can control this agent in human beings. Undoubtedly, the benefits will not come soon enough fo r all but an apparatus capable of attacking this problem rationally is currently in place. Furthermore, previous experience with persistent viral infections suggests that there is much work ahead. Experienced investigators know that the ract that vaccines can be produced does not mean that the whole problem can be dealt with quickly . Instead, we will most probably need a combination or errective diagnostic tools, vacci nes, and antiviral or immunocnhancing therapy (or both) to provide disease control for all who are at risk.
